Dyadic International, Inc.
(NASDAQ : DYAI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -1.24%63.151.0%$510.50m
AMGNAmgen, Inc. -4.02%225.591.3%$451.51m
BIIBBiogen, Inc. -2.14%278.141.4%$375.15m
ILMNIllumina, Inc. -2.27%319.583.5%$322.74m
VRTXVertex Pharmaceuticals, Inc. -2.07%229.061.9%$273.01m
REGNRegeneron Pharmaceuticals, Inc. -3.17%345.282.6%$238.76m
EXASEXACT Sciences Corp. -2.83%89.5724.0%$223.37m
ALXNAlexion Pharmaceuticals, Inc. -3.02%105.272.0%$170.84m
AAgilent Technologies, Inc. -0.92%88.251.6%$130.79m
INCYIncyte Corp. -1.92%76.742.5%$127.16m
BMRNBioMarin Pharmaceutical, Inc. 0.61%86.154.3%$108.27m
SRPTSarepta Therapeutics, Inc. -1.14%112.3914.6%$108.00m
SGENSeattle Genetics, Inc. -1.54%113.576.1%$103.89m
BLUEbluebird bio, Inc. -2.74%87.2614.2%$86.40m
DERMDermira, Inc. -0.27%18.713.8%$83.32m

Company Profile

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.